Patents Assigned to Elysium Health, Inc.
-
Patent number: 12128060Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.Type: GrantFiled: June 16, 2022Date of Patent: October 29, 2024Assignee: Elysium Health, Inc.Inventors: Ryan Dellinger, Santiago Roel Santos, Eric A. Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
-
Patent number: 12109206Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.Type: GrantFiled: July 25, 2022Date of Patent: October 8, 2024Assignee: Elysium Health, Inc.Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
-
Patent number: 12043616Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.Type: GrantFiled: August 12, 2022Date of Patent: July 23, 2024Assignee: Elysium Health, Inc.Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
-
Patent number: 11998561Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating neurodegenerative disorders, and methods of treating neurodegenerative disorders using these compositions and their equivalents are described. The neurodegenerative disorders that can be treated using these compositions or methods can include Parkinson's disease, Huntington's disease, Alzheimer's disease, and the like. In an embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene can be prepared as oral formulations. In some embodiments, a dietary supplement comprises nicotinamide riboside and/or pterostilbene or equivalents.Type: GrantFiled: January 21, 2022Date of Patent: June 4, 2024Assignee: Elysium Health, Inc.Inventors: Eric Alexander Marcotulli, Daniel Antonio Alminana
-
Patent number: 11730751Abstract: Provided herein are methods and compositions related to treating motor neuron diseases, such as ALS, in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.Type: GrantFiled: May 16, 2018Date of Patent: August 22, 2023Assignees: UNIVERSITAT DE VALÈNCIA-ESTUDI GENERAL, FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR, Elysium Health, Inc.Inventors: José Maria Estrela Ariguel, José Enrique De La Rubia Orti, Ryan Dellinger
-
Patent number: 11629163Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.Type: GrantFiled: June 29, 2018Date of Patent: April 18, 2023Assignee: Elysium Health, Inc.Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
-
Patent number: 11426398Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.Type: GrantFiled: February 25, 2016Date of Patent: August 30, 2022Assignee: Elysium Health, Inc.Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
-
Patent number: 11414407Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.Type: GrantFiled: December 20, 2018Date of Patent: August 16, 2022Assignee: Elysium Health, Inc.Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
-
Patent number: 11389468Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.Type: GrantFiled: March 16, 2018Date of Patent: July 19, 2022Assignee: Elysium Health, Inc.Inventors: Ryan Dellinger, Santiago Roel Santos, Eric Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
-
Patent number: 11260069Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating neurodegenerative disorders, and methods of treating neurodegenerative disorders using these compositions and their equivalents are described. The neurodegenerative disorders that can be treated using these compositions or methods can include parkinson's disease, huntington's disease, alzheimer's disease, and the like. In an embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene can be prepared as oral formulations. In some embodiments, a dietary supplement comprises nicotinamide riboside and/or pterostilbene or equivalents.Type: GrantFiled: August 22, 2017Date of Patent: March 1, 2022Assignee: Elysium Health, Inc.Inventors: Eric Alexander Marcotulli, Daniel Antonio Alminana
-
Patent number: 11129843Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.Type: GrantFiled: April 23, 2018Date of Patent: September 28, 2021Assignee: Elysium Health, Inc.Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris